CANNABIS Q & A

13 Dec CANNABIS Q & A

Posted at 10:15h in News & Updates by Ntokozo Msiza

Download PDF

Tags:

Cannabis, CBD, Q & A, SAHPRA

Facebook Feed

6 days ago

SAHPRA and Rollout to President and Deputy President

Media release:

SAHPRA has approved the protocol amendment of the J&J implementation study targeted at Health Care Workers (HCW) for the inclusion of the President and the Deputy President. Whilst ... See more

SAHPRA has approved the protocol amendment of the J&J implementation study targeted at Health Care Workers (HCW)...

View on facebook

6 days ago

SAHPRA and the SputnikV vaccine

Media release:

SAHPRA has NOT received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia as has been reported.

Read more: https://bit.ly/3u7Hol1

#vaccinecovid19 #SAHPRA #sputniknews ... See more

SAHPRA has NOT received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia as has been reported.

View on facebook

1 week ago

Carte Blanche Ivermectin

Carte Blanche on Ivermectin: CEO and Board Chair of SAHPRA discuss the Ivermectin issue

CEO and Board Chair of SAHPRA discuss the Ivermectin issue

View on facebook

3 weeks ago

SAHPRA clarifies its stance on Ivermectin

There is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others the Afriforum regarding access to Ivermectin. SAHPRA wishes to ... See more

There is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others Afriforum.

View on facebook

4 weeks ago

SAHPRA AUTHORISES COVISHIELD - AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19 - SAHPRA

In an effort to enable and support the country’s response in fighting the #COVID19 pandemic, SAHPRA has on 22 January 2021 granted a Section 21 authorisation to the National Department of Health ... See more

In an effort to enable and support the country’s response in fighting the COVID-19 pandemic, SAHPRA has on 22 January 2021 granted a Section 21 authorisation to the Department of Health for ... See more

View on facebook

4 weeks ago

Media Briefing on Ivermectin

The South African Health Products Regulatory Authority (SAHPRA) holds a press conference to brief the media on the latest update regarding Ivermectin.

View on facebook

1 month ago

HealthTalk SABC 21Jan2021

Follow the discussion on Ivermectin on SABC 2

View on facebook

1 month ago

Good evening

Please note that the press conference scheduled for Monday, 25 January 2021 has been canceled.

The National Department of Health (South Africa) will hold a similar press conference on ... See more

View on facebook

1 month ago

National Department of Health (South Africa)

Scientific Discussion on the new variant, 501Y.V2

View on facebook

1 month ago

Photos from Sahpra's post

SAHPRA would like to confirm that there has been miscommunication between our officials and Netwerk24 regarding Ivermectin. Following clarification between both parties, Netwerk24 has issued an ... See more

View on facebook

« ‹ 1 of 2 › »

Twitter Feed

SAHPRAFollow

Retweet on Twitter SAHPRA Retweeted

NICD@nicd_sa·

21 Feb

#COVID19 UPDATE: A total of 24 856 tests were conducted in the last 24 hrs, with 1 429 new cases, which represents a 6% positivity rate. A further 113 #COVID19 related deaths have been reported, bringing total fatalities to 49 053 to date. Read more here: http://ow.ly/t93G50DFWUv

Reply on Twitter 1363584055871209477 Retweet on Twitter 136358405587120947723 Like on Twitter 136358405587120947737 Twitter 1363584055871209477

13 Dec CANNABIS Q & A

Tags:

SAHPRA clarifies its stance on Ivermectin

SAHPRA AUTHORISES COVISHIELD – AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19

SAHPRA OTC ONLINE DIRECTORY

Extension of Post Importation Testing Exemptions

Frequently Asked Questions: New Variant of SARS-CoV-2 in South Africa

INFORMATION AND GUIDANCE ON IMMUNIZATION WITH THE NEW COVID-19 VACCINES

CONTACT US

Quick Menu

I want to..

Newsletter Subscription

Follow us